Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein

1 Sept 1998

Abstract excerpt

Recently, alpha-synuclein was shown to be a structural component of the filaments in Lewy bodies (LBs) of Parkinson's disease (PD), dementia with LBs (DLB) as well as the LB variant of Alzheimer's disease, and this suggests that alpha-synuclein could play a mechanistic role in the pathogenesis of these disorders. To determine whether alpha-synuclein is a building block of inclusions in other neurodegenerative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9749615
DOI: 10.1002/ana.410440324

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synucleinPMID 9749615Read ↗

Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophySemantic proximity Read ↗

α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophySemantic proximity Read ↗

Alpha-synuclein and the Lewy body disorders.Semantic proximity Read ↗

Alpha-synuclein dysfunction in Lewy body diseases.Semantic proximity Read ↗

Alpha‐synuclein mRNA expression in oligodendrocytes in MSASemantic proximity Read ↗

Neurodegeneration and the ordered assembly of α-synucleinSemantic proximity Read ↗

Immunohistochemical and Biochemical Studies Demonstrate a Distinct Profile of α-Synuclein Permutations in Multiple System AtrophySemantic proximity Read ↗

Extracellular Interactions of Alpha-Synuclein in Multiple System AtrophySemantic proximity Read ↗

Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human α-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System AtrophySemantic proximity Read ↗

Pathological Endogenous α-Synuclein Accumulation in Oligodendrocyte Precursor Cells Potentially Induces Inclusions in Multiple System AtrophySemantic proximity Read ↗

Parkinsons Disease and other α-SynucleinopathiesSemantic proximity Read ↗

The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System AtrophySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.